Chimeric Antigen by the Fusion of SARS-CoV-2 Receptor Binding Domain with the Extracellular Domain of Human CD154: A Promising Improved Vaccine Candidate.
Ávalos I, Lao T, Rodríguez EM, Zamora Y, Rodríguez A, Ramón A, Lemos G, Cabrales A, Bequet-Romero M, Casillas D, Andújar I, Espinosa LA, González LJ, Alvarez Y, Carpio Y, Estrada MP.
Ávalos I, et al. Among authors: bequet romero m.
Vaccines (Basel). 2022 Jun 3;10(6):897. doi: 10.3390/vaccines10060897.
Vaccines (Basel). 2022.
PMID: 35746505
Free PMC article.